Navigation Links
InVitria Showcases Cell Culture Productivity Enhancers at BioProcess International
Date:9/12/2008

FORT COLLINS, Colo., Sept. 12 /PRNewswire/ -- InVitria (http://www.InVitria.com), a leading global supplier of animal free products that enhance productivity, safety and time to market for companies in the biopharmaceutical, cell culture, life science research and diagnostics industry, will be an exhibitor and presenter at the BioProcess International Conference and Exhibition in Anaheim, California on September 23-26. (http://www.ibclifesciences.com/B8171/overview.xml)

"This is a major annual event for the bioprocessing industry and we will showcase the productivity improvements our customers have experienced by using our line of cell culture ingredients," said Brandy Sargent, InVitria Account Manager. "Two InVitria products -- Cellastim and Lacromin -- can replace bovine or human sources of albumin or transferrin and provide better productivity, enhanced safety and more consistent results. Our customers have asked for animal free products and products that improve their productivity. InVitria's products deliver on both."

About InVitria (http://www.InVitria.com)

InVitria has developed animal free cell culture ingredients that enhance productivity, safety and time to market for companies in the biopharmaceutical, cell culture, life science research and diagnostics industry. InVitria's animal free product line includes:

-- Cellastim -- Cellastim is an albumin used to replace bovine albumin and

human albumin as a cell culture ingredient and biopharmaceutical

formulation excipient. Cellastim is a recombinant protein and has been

shown to improve mammalian cell culture productivity by up to 50% when

compared with other forms of albumin. Cellastim also has been an

effective component in stem cell media and primary cell media.

(see http://www.Cellastim.com )

-- Lacromin -- Lacromin has been shown to replace bovine transferrin and

human transferrin in cell culture media. In addition, Lacromin is a

strong growth promotant as a cell culture ingredient in mammalian cell

culture media. (see http://www.Lacromin.com )

-- Lysobac -- Lysobac is a bacterial cell lysis agent that is more

efficient and more consistent compared to chicken lysozyme and provides

higher protein yield compared with mechanical cell lysis. Lysobac is

used in bacterial fermentation to improve recombinant protein

yields.(see http://www.Lysobac.com )

For more information about the InVitria line of products, please e-mail info@InVitria.com or call 1-800-916-8311.


'/>"/>
SOURCE InVitria
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Siemens Showcases Its Most Comprehensive and Advanced Breast Care Portfolio
2. ACORN Showcases Oncology CRO, EDC, PRO and Data Warehouse at 44th Annual DIA Meeting
3. Sanofi Pasteur Initiates Phase II Trial of Cell Culture-Based Seasonal Influenza Vaccine
4. Agriculture Department Warns Consumers of Tainted Raw Milk Sold by Chester County Dairy
5. BD Announces FDA 510(k) Clearance of Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures
6. Agriculture Department Warns Consumers of Tainted Raw Milk Sold by Lebanon County Dairy
7. AdvanDx Submits Yeast Traffic Light PNA FISH(TM) for FDA 510(k) Clearance for Detection of Candida species in Positive Blood Cultures
8. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
9. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
10. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
11. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016 Research ... Devices Global Market - Forecast to 2022" report to ... the treatment method for the patients with kidney failure, it ... excess fluid from the patient,s blood and thus the treatment ... potassium and chloride in balance. Increasing number ...
(Date:6/23/2016)... -- In a startling report released today, National Safety Council ... comprehensive, proven plan to eliminate prescription opioid overdoses. Prescription ... are tackling the worst drug crisis in recorded U.S. history, assigned ... Kentucky , New Mexico , ... 28 failing states, three – Michigan , ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their ... Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. , ... Pro X users can now reveal the media of their split screens with ...
(Date:6/27/2016)... , ... June 27, 2016 , ... TopConsumerReviews.com recently awarded ... Eyeglasses . , Millions of individuals in the United States and Canada wear ... a way to both correct vision and make a fashion statement. Even celebrities use ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... that was developed to enhance the health of felines. The formula is all-natural and ... main herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, can now ... and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings ... The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the ...
(Date:6/25/2016)... ... 2016 , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his ... David Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps ... in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to ...
Breaking Medicine News(10 mins):